This project aims to advance the commercialization strategy of a closed-loop microneedle-based biosensing platform for real-time therapeutic drug monitoring. The technology integrates hydrogel microneedles with electrochemical aptamer-based sensors to continuously measure drug concentrations in interstitial fluid and enable adaptive dosing. Initially developed for vancomycin monitoring, the platform addresses critical limitations of conventional therapeutic drug monitoring, […]
Read More